Long-term use of temozolomide: Could you use temozolomide safely for life in gliomas?

Journal of Clinical Neuroscience

Volumn 16, Issue 6, 2009, Pages 854-855

  Khasraw, Mustafa ^a   Bell, David ^a   Wheeler, Helen ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Glioblastoma multiforme; Glioma; Temozolomide

Indexed keywords

CARABAMAZEPINE; DEXAMETHASONE; GABAPENTIN; GLUCOCORTICOID; TEMOZOLOMIDE; THALIDOMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; CRANIOTOMY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; DACARBAZINE; DRUG TOXICITY; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; RADIOTHERAPY; RETROSPECTIVE STUDIES; TIME; TREATMENT OUTCOME;

EID: 67349097860     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.09.005     Document Type: Article

References (8)

1. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
2. Singhal N., Selva-Nayagam S., and Brown M.P. Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature. Neuro Oncol 85 (2007) 229-230
3. Noronha V., Berliner N., Ballen K.K., et al. Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature. Neuro Oncol 8 (2006) 280-283 Epub 2006 May 25
4. Su Y.W., Chang M.C., Chiang M.F., et al. Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. J Neurooncol 71 (2005) 315-318
5. Hau P., Koch D., Hundsberger T., et al. Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology 68 (2007) 688-690
6. Colman H., Hess K., Turner M., et al. Impact of duration of temozolomide therapy on progression-free survival in recurrent malignant glioma. Neuro Oncol 4 (2002) 368 (Abstract)
7. Perry J, Mason W, Belanger K. The temozolomide RESCUE study: A phase II trial of continuous (28/28) dose-intense temozolomide (TMZ) after progression on conventional 5/28 day TMZ in patients with recurrent malignant glioma. J Clin Oncol 26:2008 (May 20 suppl; abstr 2010) Abstract.
8. Armstrong T, Cao Y, Vera E, et al. Pharmacoepidemiology of myelotoxicity (TOX) with temozolomide (TMZ) in malignant glioma patients. J Clin Oncol 26:2008 (May 20 suppl; abstr 9548) Abstract.